newsfilter
← Latest News
GlobeNewswire·

Merus Announces the Journal Publication of Petosemtamab Mechanism of Action

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS) ("Merus", "the Company", "we", or "our"), an oncology company developing innovative, full-length multispecific